Literature DB >> 16644090

Decreased lactoferrin levels in peritoneal fluid of women with minimal endometriosis.

Grzegorz Polak1, Iwona Wertel2, Rafał Tarkowski2, Dorota Morawska2, Jan Kotarski2.   

Abstract

OBJECTIVE: The aim of the study was to evaluate for the presence of lactoferrin (LTF) in peritoneal fluid (PF) of women with and without endometriosis. PATIENTS: Seventy-eight women were studied, including 49 women with endometriosis and, as a reference group, 29 patients with functional follicle ovarian cysts.
RESULTS: Lactoferrin levels were detectable in all peritoneal fluid samples. Women with minimal endometriosis had lower PF lactoferrin concentrations compared to both patients with high revised American Fertility Society classification scores and women with follicle ovarian cysts. No significant difference in the peritoneal LTF levels was found between patients with stage II endometriosis, stage III or IV endometriotic disease and women with functional cysts of ovaries.
CONCLUSIONS: Owing to its antibacterial properties lactoferrin is probably an important defense factor in the peritoneal cavity, however its role in the pathogenesis of endometriosis remains enigmatic.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16644090     DOI: 10.1016/j.ejogrb.2006.03.013

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  2 in total

1.  The Eutopic Endometrium Proteome in Endometriosis Reveals Candidate Markers and Molecular Mechanisms of Physiopathology.

Authors:  Loren Méar; Emmanuelle Com; Khadija Fathallah; Laetitia Guillot; Régis Lavigne; Blandine Guével; Arnaud Fauconnier; François Vialard; Charles Pineau
Journal:  Diagnostics (Basel)       Date:  2022-02-06

2.  SAGD: a comprehensive sex-associated gene database from transcriptomes.

Authors:  Meng-Wei Shi; Na-An Zhang; Chuan-Ping Shi; Chun-Jie Liu; Zhi-Hui Luo; Dan-Yang Wang; An-Yuan Guo; Zhen-Xia Chen
Journal:  Nucleic Acids Res       Date:  2019-01-08       Impact factor: 16.971

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.